A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

Advertising regulator launches nine investigations into weight loss jab ads - Exclusive: ASA calls number of parallel probes ...

Novo Nordisk shares rose after the drugmaker reported strong sales growth for its blockbuster obesity and diabetes drugs and issued a forecast for full-year 2025 results that topped analysts ...

It revealed that sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion ... we completed the acquisition of the three Catalent sites, and during the year, we progressed ...

Wegovy: sales of weight loss injection more than double - The company said more than 45 million people were now ‘benefitting from our treatments’ ...

It revealed that sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion ... we completed the acquisition of the three Catalent sites, and during the year, we progressed ...

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy ... via injection, but oral formats ...

Novo Nordisk shares rose as investors breathed a sigh of relief on strong sales growth and guidance despite ongoing capacity constraints and fears over the U.S. demand outlook for its blockbuster ...